Combining electromyography and Raman spectroscopy: optical EMG

Area of Science:

• Neuromuscular disease diagnostics
• Biomolecular spectroscopy
• Medical instrumentation

Background:

• Electromyography (EMG) is crucial for diagnosing neuromuscular disorders but lacks molecular insights.
• Raman spectroscopy offers specific molecular fingerprints of tissues, emerging as a potential biomarker.
• A combined approach could enhance diagnostic capabilities for muscle diseases.

Purpose of the Study:

• To introduce and validate "optical EMG," a novel technique combining EMG and Raman spectroscopy.
• To assess the feasibility of using a single needle for simultaneous electrophysiological and molecular data acquisition.
• To evaluate optical EMG's potential as a biomarker in a mouse model of amyotrophic lateral sclerosis (ALS).

Main Methods:

• Developed a specialized needle capable of collecting both electrophysiological and Raman spectroscopic data.
• Conducted in vivo experiments on SOD1^G93A transgenic mice (model of ALS) and non-transgenic controls.
• Recorded compound muscle action potentials (CMAPs), spontaneous EMG activity, and Raman spectra from gastrocnemius muscles.

Main Results:

• Optical EMG successfully recorded electrophysiological data comparable to standard EMG needles.
• Significant differences in CMAP amplitude were observed between SOD1^G93A and control mice.
• Raman spectroscopy revealed distinct molecular composition differences in muscle tissue between the groups, with spontaneous EMG activity detected only in transgenic mice.

Conclusions:

• Optical EMG provides both standard electrophysiological and molecular Raman data from a single needle insertion.
• This integrated approach demonstrates potential as a novel biomarker for neuromuscular disease diagnosis.
• The technique successfully differentiated between healthy and diseased muscle in a relevant animal model.